Search by Drug Name or NDC

    NDC 31722-0753-60 Lamivudine 150 mg/1 Details

    Lamivudine 150 mg/1

    Lamivudine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is LAMIVUDINE.

    Product Information

    NDC 31722-0753
    Product ID 31722-753_f61245ec-3e83-4bf6-bb95-8e4ff81bb6b7
    Associated GPIs 12106060000320
    GCN Sequence Number 024417
    GCN Sequence Number Description lamivudine TABLET 150 MG ORAL
    HIC3 W5J
    HIC3 Description ANTIVIRALS, HIV-SPECIFIC, NUCLEOSIDE ANALOG, RTI
    GCN 26720
    HICL Sequence Number 010215
    HICL Sequence Number Description LAMIVUDINE
    Brand/Generic Generic
    Proprietary Name Lamivudine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lamivudine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name LAMIVUDINE
    Labeler Name Camber Pharmaceuticals, Inc.
    Pharmaceutical Class Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203277
    Listing Certified Through 2024-12-31

    Package

    NDC 31722-0753-60 (31722075360)

    NDC Package Code 31722-753-60
    Billing NDC 31722075360
    Package 60 TABLET, FILM COATED in 1 BOTTLE (31722-753-60)
    Marketing Start Date 2014-01-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.84753
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description LAMIVUDINE 150 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 49d53e74-3798-4463-b817-1c8beb755034 Details

    Revised: 11/2019